by connect2pharma | Apr 13, 2026 | Blog
Trichomonas: Common, Underdiagnosed, and Still Dependent on Outdated Pathways Trichomonas vaginalis is one of the most common non-viral sexually transmitted infections globally. And yet, in many healthcare settings, it remains under-recognised, inconsistently tested...
by connect2pharma | Apr 13, 2026 | Blog
The Problem Isn’t Cholesterol Testing It’s Timing Cholesterol testing is one of the most established tools in cardiovascular prevention. It’s widely available. It’s routinely used. And it plays a central role in everything from NHS Health Checks to long-term condition...
by connect2pharma | Apr 13, 2026 | Blog
Strep Testing in Primary Care: If the Evidence Exists, Why Hasn’t Guidance Changed? Sore throat is one of the most common presentations in primary care. It’s also one of the most debated. Because behind a seemingly simple symptom lies a difficult clinical challenge:...
by connect2pharma | Apr 13, 2026 | Blog
Lp(a) Isn’t Just Another Lipid It’s a Distinct Cardiovascular Risk Pathway For decades, cardiovascular risk assessment has been dominated by traditional lipid markers — particularly LDL cholesterol. And for good reason. LDL is well understood, measurable, and,...
by connect2pharma | Apr 13, 2026 | Blog
Health Checks Work But What Happens Next? Rethinking Cholesterol Testing in Preventative Care. Cholesterol testing sits at the heart of cardiovascular risk assessment. It’s one of the most widely used and accessible tools in preventative healthcare — and a core...
by connect2pharma | Apr 13, 2026 | Blog
What’s Actually Happened with ACR in QOF – and Why It Matters Urine ACR (albumin-to-creatinine ratio) is one of the most clinically important tests in identifying early kidney disease. It plays a key role in: Detecting chronic kidney disease (CKD) Stratifying...
